Skip to content

Clinical trials

Phase 1 Bone Diseases, Metabolic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bone Diseases, Metabolic Phase: Phase 1 Country / region: United States Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20061
20081
20101
20112
20131
20152
20161
20171
20191
20201
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated2
Active, not recruiting1
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Duquesne University3
Amgen1
Canopy Growth Corporation1
Mayo Clinic1
Nancy E. Lane, MD1
Nationwide Children's Hospital1
POM Wonderful LLC1
Pfizer1
Purdue University1
Tufts Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bone Diseases, Metabolic16
Osteoporosis7
Adrenal Insufficiency1
Anxiety Disorders1
Arthritis1
Arthritis, Rheumatoid1
Bone Diseases1
Bone Resorption1
Diabetes Mellitus1
Diabetes Mellitus, Type 21

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.